why choose us

First received: February 19, 2026

Clinical Trial: Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: PCOS(Insulin Resistant)

Study Type: INTERVENTIONAL


Official Title: Effect of Pioglitazone on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS in Comparison to Metformin

Brief Summary: Women with PCOS with HOMA-IR >2 fulfilling inclusion and exclusion criteria are randomly allocated into two groups: group A: pioglitazone 30 mg once daily and group B: Metformin 500 thrice daily for 3 months.Each group contains 30 participants.Outcome variables are measured after 3 months.

Read more